4.4 Article

Influence of patients' socioeconomic status on clinical management decisions: A qualitative study

Journal

ANNALS OF FAMILY MEDICINE
Volume 6, Issue 1, Pages 53-59

Publisher

ANNALS FAMILY MEDICINE
DOI: 10.1370/afm.749

Keywords

-

Funding

  1. NATIONAL INSTITUTE ON AGING [R01AG001934] Funding Source: NIH RePORTER
  2. NIA NIH HHS [T32AG1934] Funding Source: Medline

Ask authors/readers for more resources

PURPOSE Little is known about how patients' socioeconomic status (SES) influences physicians' clinical management decisions, although this information may have important implications for understanding inequities in health care quality. We investigated physician perspectives on how patients' SES influences care. METHODS The study consisted of in-depth semistructured interviews with primary care physicians in Connecticut. Investigators coded interviews line by line and refined the coding structure and interview guide based on successive interviews. Recurrent themes emerged through iterative analysis of codes and tagged quotations. RESULTS We interviewed 18 physicians from varied practice settings, 6 female, 9 from minority racial backgrounds, and 3 of Hispanic ethnicity. Four themes emerged from our interviews: (1) physicians held conflicting views about the effect of patient SES on clinical management, (2) physicians believed that changes in clinical management based on the patient's SES were made in the patient's interest, (3) physicians varied in the degree to which they thought changes in clinical management influenced patient outcomes, and (4) physicians faced personal and financial strains when caring for patients of low SES. CONCLUSIONS Physicians indicated that patient SES did affect their clinical management decisions. As a result, physicians commonly undertook changes to their management plan in an effort to enhance patient outcomes, but they experienced numerous strains when trying to balance what they believed was feasible for the patient with what they perceived as established standards of care.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.4
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Letter Health Care Sciences & Services

Demographic Characteristics of Participants in Trials Essential to US Food and Drug Administration Vaccine Approvals, 2010-2020

Audrey D. Zhang, Jeremy Puthumana, Alexander C. Egilman, Jason L. Schwartz, Joseph S. Ross

JOURNAL OF GENERAL INTERNAL MEDICINE (2022)

Article Medicine, General & Internal

Consistency between trials presented at conferences, their subsequent publications and press releases

Anisa Rowhani-Farid, Kyungwan Hong, Mikas Grewal, Jesse Reynolds, Audrey D. Zhang, Joshua D. Wallach, Joseph S. Ross

Summary: This study examined the consistency of reporting study design, end points, and results of clinical trials presented at major international medical conferences in conference abstracts, published article abstracts, and press releases. The results showed that primary efficacy endpoint definitions were consistently reported, while reporting consistency rates were lower for sample sizes, follow-up periods, and effect size estimates.

BMJ EVIDENCE-BASED MEDICINE (2023)

Letter Biotechnology & Applied Microbiology

Challenges and solutions to advancing heath equity with medical devices

Kushal T. Kadakia, Vinay K. Rathi, Reshma Ramachandran, James L. Johnston, Joseph S. Ross, Sanket S. Dhruva

NATURE BIOTECHNOLOGY (2023)

Editorial Material Medicine, General & Internal

Ensuring Public Trust in an Empowered FDA

Joseph S. S. Ross, Karina M. M. Berg, Reshma Ramachandran

NEW ENGLAND JOURNAL OF MEDICINE (2023)

Letter Cardiac & Cardiovascular Systems

Trends in Spending and Claims for P2Y12 Inhibitors by Medicare and Medicaid From 2015 to 2020

Mohammed Essa, Joseph S. S. Ross, Sanket S. S. Dhruva, Nihar R. R. Desai, Robert W. W. Yeh, Kamil F. F. Faridi

JOURNAL OF THE AMERICAN HEART ASSOCIATION (2023)

Article Health Care Sciences & Services

Longitudinal Patterns in Testosterone Prescribing After US FDA Safety Communication in 2014

Ashwini Sankar, Alexander O. Everhart, Anupam B. Jena, Molly M. Jeffery, Joseph S. Ross, Nilay D. Shah, Pinar Karaca-Mandic

Summary: This study aimed to describe the changes in testosterone prescribing following a 2014 FDA safety communication and investigate the relationship between these changes and physician characteristics. The study found that testosterone prescriptions declined after the safety communication, and certain physician characteristics were associated with changes in off-label prescribing.

JOINT COMMISSION JOURNAL ON QUALITY AND PATIENT SAFETY (2023)

Article Engineering, Biomedical

Characterization of US Food and Drug Administration Class I Recalls from 2018 to 2022 for Moderate- and High-Risk Medical Devices: A Cross-Sectional Study

Maryam Mooghali, Joseph S. Ross, Kushal Kadakia, Sanket S. Dhruva

Summary: This study analyzed Class I medical device recalls and found that recalls are initiated to address safety concerns and have a significant impact on patients' lives. The recall process involves identifying, assessing, and correcting or removing affected devices. The study revealed that a large number of medical devices are affected by Class I recalls, and it takes a considerable amount of time to terminate a recall.

MEDICAL DEVICES-EVIDENCE AND RESEARCH (2023)

Article Medicine, General & Internal

US Food and Drug Administration regulatory reviewer disagreements and postmarket safety actions among new therapeutics

Ashley Eadie, Andrea MacGregor, Joshua Wallach, Joseph Ross, Matthew Herder

Summary: This study found that 24% of novel therapeutics approved by the US FDA between 2011 and 2015 had regulatory reviewer disagreements. These therapeutics with disagreements had fewer postmarket safety actions and were more likely to carry a black box warning at the point of approval.

BMJ EVIDENCE-BASED MEDICINE (2023)

Letter Cardiac & Cardiovascular Systems

Payer-Negotiated Prices for Cardiac Electrophysiology Procedures at 2022-2023 Top 100 US News & World Report for Cardiology and Heart Surgery Hospitals

Kunal Gupta, Ravi Gupta, Roy Xiao, Vinay K. Rathi, P. Elliott Miller, Joseph S. Ross, Sanket S. Dhruva

CIRCULATION-ARRHYTHMIA AND ELECTROPHYSIOLOGY (2023)

Letter Medicine, Research & Experimental

Industry payments and brand-name tyrosine kinase inhibitor use amid generic entry

Q. Wilton Sun, Howard P. Forman, Joseph S. Ross

CLINICAL TRIALS (2023)

Editorial Material Medicine, General & Internal

The Accelerated Approval Program for Cancer Drugs - Finding the Right Balance

Bishal Gyawali, Aaron S. Kesselheim, Joseph S. Ross

Summary: The FDA has proposed updated guidance for the accelerated approval pathway for cancer drugs, which could be improved despite including important provisions.

NEW ENGLAND JOURNAL OF MEDICINE (2023)

Article Multidisciplinary Sciences

Clinical trial data sharing: a cross-sectional study of outcomes associated with two US National Institutes of Health models

Anisa Rowhani-Farid, Mikas Grewal, Steven Solar, Allen O. Eghrari, Audrey D. Zhang, Cary P. Gross, Harlan M. Krumholz, Joseph S. Ross

Summary: The impact and effectiveness of clinical trial data sharing initiatives may vary depending on the data sharing model. By comparing the centralized model used by NHLBI and the decentralized model used by NCI, we found that more NHLBI-funded trials shared data and had more shared data publications. This suggests that the centralized data sharing model is more effective in promoting data sharing.

SCIENTIFIC DATA (2023)

Article Surgery

Medical device risk (re)classification: lessons from the FDA's 515 Program Initiative

Maryam Mooghali, Vinay K. Rathi, Kushal T. Kadakia, Joseph S. Ross, Sanket S. Dhruva

BMJ SURGERY INTERVENTIONS & HEALTH TECHNOLOGIES (2023)

Article Health Care Sciences & Services

An explainable machine learning-based phenomapping strategy for adaptive predictive enrichment in randomized clinical trials

Evangelos K. Oikonomou, Phyllis M. Thangaraj, Deepak L. Bhatt, Joseph S. Ross, Lawrence H. Young, Harlan M. Krumholz, Marc A. Suchard, Rohan Khera

Summary: In this study, a machine learning strategy using computational trial phenomaps was proposed to optimize enrollment in randomized clinical trials (RCTs). Simulated analyses showed that the strategy could predict individual cardiovascular benefits and adjust enrollment probability accordingly, leading to a reduction in trial size while preserving the original treatment effect.

NPJ DIGITAL MEDICINE (2023)

Article Surgery

Exploring unique device identifier implementation and use for real-world evidence: a mixed-methods study with NESTcc health system network collaborators

Sanket S. Dhruva, Jennifer L. Ridgeway, Joseph S. Ross, Joseph P. Drozda Jr, Natalia A. Wilson

Summary: This study examined the current state of UDI implementation among eight health systems and identified barriers and facilitators. The results showed that UDI adoption requires knowledge and impetus, and the availability of UDIs also impacts medical device research.

BMJ SURGERY INTERVENTIONS & HEALTH TECHNOLOGIES (2023)

No Data Available